Flynn, Robert

Superintendent Pharmacist, Molecular and Clinical Medicine

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Robert Flynn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

1 Finished

Application of Support Vector Machine Learning to Predict the Risk of Death from Chronic Obstructive Pulmonary Disease Using Electronic Primary Care Medical Records
Flynn, R., Morales, D. & Zhang, J.
1/07/15 → 30/06/16
Project: Research

1059 Citations
14 h-Index
26 Article
9 Book/Film/Article review
3 Special issue
3 Review article
More
- 2 Meeting abstract
- 2 Letter

Factors influencing home blood pressure monitor ownership in a large clinical trial
Anbarasan, T., Rogers, A., Rorie, D. A., Grieve, J. W. K., Flynn, R., MacDonald, T. M. & Mackenzie, I. S., 2 Mar 2021, (E-pub ahead of print) In: Journal of Human Hypertension. 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Downloads (Pure)
Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride
Ruigómez, A., Plana, E., Gilsenan, A., Fortuny, J., Cainzos-Achirica, M., Flynn, R. W. V., MacDonald, T. M., Garcia-Rodriguez, L., Ziemiecki, R. & Andrews, E. B., May 2021, In: Drug Safety. 44, p. 541-551 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
12 Downloads (Pure)
Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee
Flynn, R., Hedenmalm, K., Murray-Thomas, T., Pacurariu, A., Arlett, P., Shepherd, H., Myles, P. & Kurz, X., 12 Feb 2020, In: Clinical Pharmacology and Therapeutics. 107, 4, p. 957-965 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Citation (Scopus)

107 Downloads (Pure)
Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands
Morales, D. R., Morant, S. V., MacDonald, T. M., Mackenzie, I. S., Doney, A. S. F., Mitchell, L., Bennie, M., Robertson, C., Hallas, J., Pottegard, A., Ernst, M. T., Wei, L., Nicholson, L., Morris, C., Herings, R. M. C., Overbeek, J. A., Smits, E. & Flynn, R. W. V., Mar 2020, In: Pharmacoepidemiology and Drug Safety. 29, 3, p. 296-305 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
2 Citations (Scopus)

23 Downloads (Pure)
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: interrupted time series regression analysis
Morales, D. R., Morant, S. V., MacDonald, T. M., Hallas, J., Ernst, M. T., Pottegard, A., Herings, R. M. C., Smits, E., Overbeek, J. A., Mackenzie, I. S., Doney, A. S. F., Mitchell, L., Bennie, M., Robertson, C., Wei, L., Nicholson, L., Morris, C. & Flynn, R. W. V., 15 Jul 2020, (E-pub ahead of print) In: British Journal of Clinical Pharmacology. 87, 3, p. 1129-1140 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
2 Citations (Scopus)

13 Downloads (Pure)

Application of Support Vector Machine Learning to Predict the Risk of Death from Chronic Obstructive Pulmonary Disease Using Electronic Primary Care Medical Records

Factors influencing home blood pressure monitor ownership in a large clinical trial

Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride

Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee

Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands

Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: interrupted time series regression analysis